본문으로 건너뛰기
cccskills
무료GitHub에 공개

endo-csii-continue-hospital-if-protocols

Suggests that clinicians continue CSII in hospitalized patients with type 1 or type 2 diabetes when the institution has clear protocols for evaluating pump candidates and appropriate monitoring and safety procedures. Trigger phrases include: 'Admitted patient on pump, check hospital pump policy' and 'Inpatient with diabetes using pump, verify institutional guidelines'.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

실행 점수 미검증

설치 방법 보기

포함된 파일(1)

  • SKILL.md2.4 KB

SKILL.md(원문)

설치하기 전에 에이전트에게 전달되는 지시 내용을 확인할 수 있습니다.

Suggest continuing CSII in hospital if protocols exist

STEP 1 — Gather Information

Confirm hospitalization, diabetes type (T1DM or T2DM), current home CSII use, and whether the hospital has a written protocol for evaluating insulin pump candidates and for monitoring/safety during inpatient stay.

STEP 2 — Rule In / Rule Out

Is there an institutional protocol for evaluating CSII candidates and appropriate monitoring/safety? If yes, proceed to Step 3; if no, recommend discontinuing CSII and transitioning to basal-bolus insulin infusion (or MDI) per inpatient glycemic management guidelines.

STEP 3 — Classify or Stratify

Assess patient suitability using the hospital’s pump criteria: ability to self-manage pump, no contraindications (e.g., DKA risk, altered mental status, NPO without pump plan), and availability of nursing support familiar with pump therapy. Classify as suitable or unsuitable.

STEP 4 — Decide

If suitable and protocols exist, continue CSII with frequent glucose monitoring (pre-meal, bedtime, and as needed) and adjust basal/bolus per protocol; if unsuitable, discontinue pump and initiate scheduled basal-bolus insulin or insulin infusion per hospital order sets.

Clinical Guardrails / Mimics / Pitfalls

Do not continue CSII if the patient cannot operate the pump, is NPO without a plan for pump management, has recurrent hypoglycemia unawareness, or if nursing staff lack pump training; avoid assuming continuation without verifying institutional policy to prevent medication errors and safety events.

Concrete Clinical Example

A 62-year-old man with type 1 diabetes admitted for bowel resection uses an insulin pump at home; the hospital has a pump policy, he is alert and capable, and nursing is trained; his pump is continued with glucose checks every 4 hours and basal rates adjusted per surgical stress.

Source: Insulin pump use in the hospital, Endocrine Society Clinical Practice Guideline, 2016, DOI:10.1210/jc.2016-2534

리뷰

아직 리뷰가 없습니다. 사용해 본 소감을 남겨 주세요.

댓글

로그인 없이 쓸 수 있습니다. 사용 후기, 질문, 작동하지 않은 환경 등을 편하게 남겨 주세요.

아직 댓글이 없습니다. 첫 댓글을 남겨 보세요.

보내면 바로 공개됩니다. 이메일 주소나 전화번호 같은 개인 정보는 쓰지 마세요. URL은 2개까지입니다.

0 / 1,000자

이 양식은 reCAPTCHA로 보호되며 Google 개인정보처리방침 및 서비스 약관이 적용됩니다.

같은 저장소의 스킬

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

dromlakhani의 스킬 모두 보기

이 스킬의 문제 신고